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Abstract: 
 
 
Background & Aims: The National Early Warning Score (NEWS) is used to identify 
deteriorating adult hospital inpatients. However, it includes physiological parameters 
frequently altered in patients with cirrhosis. We aimed to assess the performance of the 
NEWS in acute and chronic liver diseases. 
 
Methods: We collected vital signs, recorded in real time, from completed consecutive 
admissions of patients 16 years or older to a large acute-care hospital in Southern England, 
from January 1, 2010 through October 31, 2014. Using ICD-10 codes, we categorized 
patients as having primary liver disease, secondary liver disease, or none. For patients with 
liver disease, 2 analysis groups were developed: the first based on clinical group (such as 
acute or chronic, alcohol-induced, or associated with portal hypertension) and the second 
based on summary liver-related hospital-level mortality indicator diagnoses. For each, we 
compared the abilities of the NEWS and 34 other early warning scores to discriminate 24-hr 
mortality, cardiac arrest, or unanticipated admission to the intensive care unit using area 
under the receiver operating characteristics (AUROC) curve and early warning score 
efficiency curve analyses. 
 
Results: The NEWS identified patients with primary, non-primary, and no diagnoses of liver 
disease with AUROC values of 0.873 (95% CI, 0.860–0.886), 0.898 (95% CI, 0.891–0.905), 
and 0.879 (95% CI, 0.877–0.881), respectively. High AUROC values were also obtained for 
all clinical subgroups; the NEWS identified patients with alcohol-related liver disease with an 
AUROC value of 0.927 (95% CI, 0.912–0.941). The NEWS identified patients with liver 
diseases with higher AUROC values than other early warning scoring systems. 
 
Conclusion: The NEWS accurately discriminates patients at risk of death, admission to the 
intensive care unit, or cardiac arrest within a 24-hr period for a range of liver-related 
diagnoses. Its widespread use provides a ready-made, easy to use option for identifying 
patients with liver disease who require early assessment and intervention, without the need 
to modify parameters, weightings or escalation criteria. 
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 INTRODUCTION 
 
Hospitalized patients with chronic liver disease (CLD) can rapidly deteriorate, particularly 
when acute decompensation is accompanied by extrahepatic organ dysfunction, a situation 
associated with high mortality.1 Early recognition of clinical deterioration is vital if effective, 
goal-directed therapies are to be employed before complications develop.2 
 
Clinical early warning scores (EWS) can identify patients at high risk of mortality3 and are 
deployed in many hospitals in the USA and Europe.4  Many different EWS are available 
(Supplementary Table 1) and to reduce variation in the United Kingdom (UK), a National 
EWS (NEWS) was launched by the Royal College of Physicians for use in all adults except 
pregnant women (Supplementary Table 2).5  NEWS allocates weighted points, based on 
derangement of vital signs from defined normal ranges.  The sum of allocated points directs 
changes in the level of care e.g. more frequent monitoring, involvement of senior staff, calling 
a rapid response team.   
 
NEWS is calculated using: pulse, respiratory rate, systolic blood pressure, AVPU (Alert-
Verbal-Painful-Unresponsive) scale, temperature, peripheral oxygen saturations (SpO2) and 
use of supplemental oxygen.  NEWS was validated in 35,585 unselected medical patients, 
achieving an area under the receiver operating characteristics (AUROC) curve [95% 
confidence interval (CI)] of 0.894 [0.887-0.902], 0.857 [0.847-0.868] and 0.722 [0.685-0.759] 
for discriminating risk of death, unanticipated intensive care unit (ICU) admission and cardiac 
arrest, within 24 hours, respectively.6   
The introduction of NEWS was timely, coinciding with a National Confidential Enquiry into 
Patient Outcome and Death (NCEPOD) report on treating patients with alcohol-related liver 
disease (ARLD) in UK hospitals, which identified widespread deficiencies in management.7  
These included poor recognition of deterioration and failure to escalate care.  Opportunities 
were missed to manage sepsis, hypovolaemia, renal failure and variceal haemorrhage 
effectively.  While current predictive models estimate medium and long-term prognosis in 
patients with liver disease, none are validated for short-term outcomes in a ward setting.  
There is an urgent need for tools to identify liver patients at risk of deterioration, which can 
be deployed outside the ICU.  
 
However, a potential concern is that many patients with liver disease have chronic 
physiological derangements affecting NEWS parameters.8  Patients with cirrhosis often have 
low systemic vascular resistance, hypotension or resting tachycardia.9,10  Pyrexial response 
may be blunted in decompensated cirrhosis and respiratory rate increased in 
encephalopathy.2 
 
These changes raise the possibility that NEWS may perform suboptimally in cirrhosis and 
other hepatic conditions. Indeed, no EWS has been specifically evaluated in liver patients.  
Therefore, the aims of our study were to determine whether NEWS accurately discriminates 
the risk of early in-hospital death, cardiac arrest or ICU admission in hospitalized patients 
with liver disease and to compare its performance against all other EWS. 
 
 
PATIENTS AND METHODS 
 
The Isle of Wight, Portsmouth and SE Hampshire research ethics committee approved our 
study (ref. 08/02/1394).  
 
Setting  
 
The study was performed in a large acute hospital in Southern England, serving 650,000 
people.  
 
Patient group  
 
We analysed a database of electronically captured vital signs recorded in real-time from 
completed consecutive admissions (episodes) of patients aged ≥ 16 years between 
01/01/2010 and 31/10/14.  Electronic NEWS recordings were in hospital-wide use excluding 
the emergency department and ICU.  Patients discharged before midnight on the day of 
admission and those admitted directly to ICU were excluded.   
 
Identification and classification of patients with liver disease 
 
Patient admissions were categorized according to International Classification of Diseases 
(ICD-10) codes for any finished consultant episode (FCE).  Data were extracted from the 
hospital’s Patient Administration System (PAS).  If care was transferred to another consultant 
or specialty during the same admission, a new FCE and further set of ICD-10 codes were 
recorded.  Groups included (1) patients with primary diagnosis of liver disease, (2) those with 
non-primary liver diagnosis (co-morbidity) and (3) patients not allocated any liver disease 
codes (control group).  Where patients had more than one FCE during admission, the final 
liver primary diagnosis or top-ranking liver secondary diagnosis (if no primary liver code) prior 
to discharge was used.  Therefore each admission could only belong to one group.   
 
ICD-10 codes were divided into four subgroups to examine NEWS performance according to 
whether liver disease was acute or chronic, alcohol-induced or associated with portal 
hypertension (Supplementary Table 3).  Clinical subgroups included: (A) acute alcohol-
induced liver injury, (B) other acute injury, (C) CLD without cirrhosis, (D) cirrhosis.  Liver-
related ICD-10 codes were identified separately using Summary Hospital-level Mortality 
Indicator (SHMI) definitions employed routinely in the UK’s National Health Service.11  Three 
previously defined SHMI groups were selected: (1) Alcohol-related liver disease (SHMI group 
93), (2) Other liver disease (SHMI group 94), and (3) Hepatitis, viral infection, other infections 
(SHMI group 6, Clinical Classification System (CCS) group 6), which includes viral hepatitis, 
autoimmune and drug-induced liver disease (Supplementary Table 4).11  Division between 
SHMI groups 93 and 94 may be relevant as ethanol can effect cardiovascular physiology 
independent of liver disease.  Patients were defined as having no liver disease if none of their 
episodes of care during, or prior to this study, contained any liver ICD-10 codes (primary or 
secondary diagnosis) identified by the three SHMI groups or four clinical subgroups.  
 
 
 
Outcomes  
 
The primary outcome was any of the following events occurring within 24 hours of an 
observation set: in-hospital mortality, unanticipated ICU admission, or cardiac arrest.    
 
Data collection 
 
Nurses recorded data required for NEWS at the bedside using electronic devices running 
VitalPACTM software.12   Vital sign sets with implausible physiological values were excluded, 
as were events for which no observations were recorded within the preceding 24 hours.  
Reasons for this included end of life care or an outcome following admission to ICU.  We 
excluded observations recorded after a primary outcome had occurred.  
 
Comparison of NEWS with other EWS 
 
To compare the performance of NEWS6 with 34 other published EWS in patients with liver 
disease, we applied each EWS to our data set.   
 
Statistics 
 
Data manipulation was performed using MicroSoft® Visual Fox-Pro 9.0. The ability of NEWS 
to discriminate outcomes was assessed using AUROC on IBM SPSSv22.  Data were 
analysed regarding (a) percentage of observations that would trigger medical review if 
escalation occurred at or above a given NEWS value and (b) percentage of observations that 
were followed by death, cardiac arrest or ICU admission within 24 hours at, or above this 
value.  EWS efficiency curves were constructed using this data.13  All observation sets were 
treated independently.  
 
 
RESULTS  
 Study population 
 
Categorising patient episodes using the four clinical subgroups, 773 patients (1197 episodes) 
were discharged with a primary diagnosis of liver disease and 2525 (3953 episodes) with 
non-primary (co-morbid) diagnosis. In the same period, if patient episodes were categorised 
using the three SHMI groups, 1216 patients (2016 episodes) were discharged with a primary 
diagnosis of liver disease and 4957 (6459 episodes) with a non-primary (co-morbid) 
diagnosis. After excluding episodes with no observations recorded 24 hours prior to an 
adverse event, the final dataset where episodes were categorised using the four clinical 
subgroups, comprised 722 patients (1112 episodes) with a primary liver diagnosis, and 2339 
patients (3658 episodes) with a non-primary liver diagnosis (Table 1). Similarly, after the 
same exclusions, the final dataset where patient episodes were categorised using the three 
SHMI groups comprised 1136 patients (1894 episodes) with a primary liver diagnosis, and 
4486 patients (5840 episodes) with a non-primary liver diagnosis (Supplementary Table 5).  
 
From these datasets we examined NEWS’ performance in liver disorders using over 3.5 
million vital sign sets.  As described in the Methods, we included all observations for analysis. 
We identified 39,619 sets from patients allocated a liver ICD-10 code as primary diagnosis 
and 105,092 from those with a non-primary liver diagnosis defined by the four clinical 
subgroups; in addition to 3,525,420 sets from those never allocated a liver ICD-10 code 
(control group) (Table 1).  Of these 2.53% (1001 / 39,619), 1.94% (2035 / 105,092), and 
0.87% (30,522 / 3,525,420) observations were followed by an adverse event within 24 hours 
respectively (Table 1). Using the SHMI classification, we identified 57,836 sets from patients 
allocated a liver primary diagnosis and 205,194 from those with a non-primary liver diagnosis 
(Supplementary Table 5).  Overall 2.19% (1269 / 57,836) and 1.91% (3917 / 205,194) of 
these observations were followed by an event within 24 hours.   
   
 
NEWS performance in primary and non-primary liver disease vs. patients without liver 
disease 
   
NEWS performed equally well in patients with primary diagnoses of liver disease with 
AUROC values [CI] of 0.873 [0.860–0.886] compared to 0.879 [0.877-0.881] for patients 
without liver disease.  NEWS achieved even higher levels of efficiency in patients with a non-
primary diagnosis of liver disease, AUROC 0.898 [0.891–0.905] (Table 2, Figure. 1). 
 
NEWS performance in four clinical subgroups of liver disease  
 
NEWS performed as well in patients with non-alcohol related acute liver injury (AUROC [CI] 
0.906 [0.879–0.933]) and CLD (AUROC [CI] 0.865 [0.835–0.894]) as it did in patients without 
liver disease (AUROC [CI] 0.879 [0.877-0.881]) (Table 2).  Compared to those without liver 
disease, NEWS performed significantly higher in acute alcohol-induced liver injury (AUROC 
[CI] 0.927 [0.912–0.941]) and slightly lower in cirrhosis (AUROC [CI] 0.824 [0.797–0.850]) 
(Table 2, Figure 2a). In patients with non-primary diagnoses of liver disease, NEWS 
performed better for several groups (all liver diagnoses combined, AUROC [CI] 0.898 [0.891–
0.905]; acute alcohol-induced liver injury, AUROC [CI] 0.929 [0.909–0.949], and CLD, 
AUROC [CI] 0.905 [0.894–0.917]) than in patients without liver disease (Table 2, Figure 2b).  
 
NEWS performance in subgroups of liver disease according to SHMI classification  
 NEWS performed equally well in patients with primary (AUROC [CI] 0.886 [0.875-0.896]) and 
non-primary (AUROC [CI] 0.880 [0.874-0.885]) liver disease defined using SHMI 
classification for all liver groups (Table 3).  NEWS performed better in ARLD than other SHMI 
liver diagnoses, both as primary (AUROC [CI] 0.902 [0.889-0.916]) and non-primary 
diagnosis (AUROC [CI] 0.915 [0.903-0.928]) (Figure 3a and 3b).  Admission numbers for 
SHMI group 6, CCS 6 were too small for meaningful interpretation.   
 
Performance of other EWS in patients with and without a primary diagnosis of liver disease 
 
NEWS performed better than the other 34 EWS evaluated for patients with a primary or non-
primary liver diagnosis (Supplementary Table 6). On dividing patients into clinical subgroups, 
NEWS performed better than the 34 EWS for those with primary or secondary diagnosis of 
acute alcohol-related injury (group A) and patients with secondary diagnosis of CLD (group 
C) (Supplemental Tables 7 and 8).  While NEWS also appeared to perform better in all 
other liver cohorts, there was no significant difference between NEWS and other high 
performing scores.  NEWS performed better than the 34 EWS for alcohol and non-alcohol 
related liver disease groups according to the SHMI classification (Supplemental Table 9).   
 
DISCUSSION 
 
In the UK, the Royal College of Physicians recommended that NEWS is deployed to 
standardize assessment of acute-illness severity in hospitals. Our study was designed to test 
the hypothesis that NEWS might not accurately predict serious events in patients with liver 
disease due to pre-existing altered physiology associated with the underlying condition.  This 
hypothesis was disproven and we were encouraged to find NEWS remained a highly 
accurate discriminator of adverse events in liver disorders, with its performance being highest 
in ARLD.  Sensitivity and specificity was slightly reduced in patients with cirrhosis but 
remained clinically relevant.  In a direct comparison with 34 other EWS systems, NEWS was 
the most discriminating in patients with primary or non-primary diagnostic codes for liver 
disease. 
 
As described in the Systemic Inflammation Hypothesis (SIH), patients with advanced liver 
disease are imperiled by progressive interactions between circulatory disturbance and 
systemic inflammation.14 These can abruptly worsen, leading to acute-on-chronic liver failure 
(ACLF), multiple organ dysfunction and death.15  To allow effective interventions, physicians 
need to be promptly alerted to deterioration.  Unfortunately many doctors fail to recognize 
deteriorating patients with liver disease.7   
 
In our study, NEWS was validated as an accurate discriminator of short-term (< 24 hour) 
deterioration of inpatients with liver disease.  The recent increase in hospital admissions 
secondary to cirrhosis in the UK16 and 43% increase in cirrhosis-associated deaths per year 
in the USA make these findings pertinent.17  NEWS’ reliance on routine vital signs facilitates 
serial monitoring, a potential advantage over many predictive scores. Its widespread adoption 
provides opportunities for standardization of care and the potential benefits.  
 
The availability of other predictors of short-term mortality for ward-based patients with CLD 
is limited. Model for End Stage Liver Disease (MELD)18,19 and UK End Stage Liver Disease 
(UKELD) scores20 are more accurate in predicting medium-term mortality.  Child-Pugh score 
is limited by two subjective parameters and a ceiling effect.21  These scoring systems, along 
with the Glasgow alcoholic hepatitis score22 and Maddrey’s discriminant function23 are reliant 
on laboratory parameters and less easily applied at the bedside for frequent monitoring.   
 
Clinical, hematological and biochemical criteria can predict short-term mortality using the 
Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health 
Evaluation (APACHE) II and Simplified Acute Physiology (SAPS) II scores, but these have 
only been validated in ICU settings.24  These prognostic models appear most accurate 48 
hours after ICU admission and may not perform optimally on general wards.25,26  The adapted 
Chronic Liver Failure (CLIF)-SOFA score and CLIF-Consortium Organ Failure score for ACLF 
(CLIF-C ACLF) were validated as predictors of 28-day transplant-free mortality.1,27 Despite 
outperforming MELD and Child-Pugh, the predictive value of CLIF-C ACLF is lowest at day 
one of diagnosis and may not reveal the earliest point of deterioration.27  Thus, none of the 
existing liver-specific scores have been validated as predictors of short-term (< 24 hour) 
mortality in a ward environment.   
 
NEWS incorporates several parameters that can be deranged in the systemic inflammatory 
response syndrome (SIRS).  This may be relevant to our finding that NEWS performs 
especially well in ARLD patients, who are particularly susceptible to sepsis.28  Alcohol misuse 
can lead to an altered intestinal microbiome, increased translocation of bacteria and elevated 
endotoxin levels.29,30  These events can worsen the liver injury itself, particularly alcoholic 
hepatitis.31,32   
 
A recent multi-centre study demonstrated strong associations between SIRS, multi-organ 
failure and death in patients with alcoholic hepatitis, independent of infection.33  Furthermore, 
alcohol-related cirrhosis may be associated with higher portal pressures and a more 
hyperdynamic circulation.34,35  Similarly, low arterial pressures and increased intrahepatic 
resistance correlate with mortality in alcohol-related ACLF.36  
 
While the efficiency of NEWS was slightly reduced in cirrhosis compared to other subgroups, 
its ability to identify acute deterioration remained high.  Importantly, AUROC values for NEWS 
in this group were higher than other EWS systems.   
 
The strength of this study lies in its access to a large electronic dataset of four years of 
hospital-wide vital signs captured at the point of care.  Exclusion rate was small (~6%), 
reflecting a valid cross-section of inpatients.  Potential weaknesses include reliance on ICD-
10 coding which may limit the accurate placement of patients into clinical subgroups.  In 
addition, this study was not designed to demonstrate whether introducing NEWS improved 
clinical care and saved lives in patients with liver diseases. This would be difficult to 
demonstrate, as NEWS is merely a clinical tool to identify patients at risk of deterioration. 
 
NEWS forms only one part of the ‘Chain of Prevention’,37 which requires staff education, 
timely vital signs monitoring, escalation of care and appropriate clinical responses. No EWS 
could be expected to improve outcomes if other components of the chain are not optimised. 
Additionally, metrics that might indicate NEWS-mediated improvements in care (e.g. 
microbiology cultures, fluid resuscitation, ICU outreach referrals) are affected by factors with 
no bearing on the performance of EWS. Furthermore, some metrics, e.g. number of ICU 
outreach referrals, might be difficult to interpret. For instance, would a reduction in the number 
of critical care referrals be a good or bad indicator? One could argue that increased referral 
to ICU implies a more pre-emptive approach to critical illness, whereas another might argue 
that fewer calls result from improved ward care.  
 
Other potential weaknesses of our study include its retrospective nature and the fact that we 
obtained date/time of death (or discharge) from the hospital’s PAS computer system.  Some 
events may have been recorded later than they occurred, potentially underestimating the 
number of observations followed by an event within 24 hours.  For simplicity, we used all 
observations for analysis. It would have been possible to randomly choose one observation 
per episode, either by randomly choosing one, or to select a random time and take the 
nearest NEWS value. However, we have previously demonstrated that whichever of these 
approaches is taken, the ranking of competing early warning systems (EWSs) is essentially 
unchanged.37 Our analysis aimed to rank performance of different EWSs and so we used the 
computationally simplest. 
 
This work could be extended by identifying whether changes in NEWS over time are more 
accurate predictors of deterioration, particularly in patients judged to be activating NEWS 
despite appearing clinically stable.  It might also be possible to combine bedside observations 
with laboratory markers to develop a scoring system with additional medium term predictive 
qualities.   
Many clinicians would agree that shock or severe sepsis are easily recognized, yet many 
doctors fail to recognize deteriorating patients with liver disease and other conditions.7,38,39 
An assessment using NEWS is easily performed by inexperienced and experienced staff 
alike. It provides an aggregate score based upon the, sometimes subtle, physiologic 
disturbance of several vital signs and may permit earlier risk stratification than when detailed 
clinical examination and initial laboratory test results are required.  However, this current 
study was not designed to determine if there was such a measurable benefit from using 
NEWS. 
 
In conclusion, we have demonstrated that NEWS accurately discriminates risk of death, ICU 
admission or cardiac arrest within 24 hours in patients with liver-related diagnoses.  Its 
widespread use in hospitals provides an easy-to-use assessment without needing to modify 
parameters, weightings or escalation criteria.  This could be particularly valuable for 
identifying patients with decompensated liver disease at risk of deterioration. 
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